Company Profile
Psomagen provides the provision omics solutions and contract laboratory services. The company's research services includes genomics, a study of gene sequence and expression. Its portfolio also includes epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell, single-cell analysis, research in suspensions, biological fluids, tissues, or cell populations, metagenomics, a study of genetic material from microorganisms in heterogeneous samples, transcriptomics, a study of RNA and its expression through sequencing, used to analyze the impact of gene expression on the biology of an organism, and proteomics, a study of all the expressed proteins in an organism (proteome), as well as Bioinformatics, a software tool and pipeline that helps scientists in analyzing data; and provides clinical genetic testing, whole-genome, whole-exome, and sanger sequencing services.
Incorporated in 2004 and headquartered in Wilmington, Delaware, Psomagen was formerly known as Macrogen Corp. before rebranding in April 2019. Psomagen, Inc. is a subsidiary of Macrogen, Inc.